Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report) was the recipient of a significant decrease in short interest in September. As of September 30th, there was short interest totaling 520 shares, a decrease of 43.3% from the September 15th total of 917 shares. Based on an average daily trading volume, of 1,835 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the company’s stock are sold short.
Institutional Investors Weigh In On Tema Heart & Health ETF
Several large investors have recently added to or reduced their stakes in the stock. Rothschild Capital Partners LLC bought a new stake in Tema Heart & Health ETF in the second quarter valued at $651,000. Royal Bank of Canada boosted its holdings in shares of Tema Heart & Health ETF by 8.8% during the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock valued at $710,000 after acquiring an additional 1,703 shares during the period. Members Advisory Group LLC acquired a new position in shares of Tema Heart & Health ETF during the second quarter valued at $398,000. Anson Capital Inc. acquired a new position in shares of Tema Heart & Health ETF during the second quarter valued at $297,000. Finally, XML Financial LLC bought a new position in shares of Tema Heart & Health ETF during the second quarter worth about $223,000.
Tema Heart & Health ETF Stock Up 2.6%
HRTS stock traded up $0.94 during midday trading on Thursday, reaching $37.28. The company had a trading volume of 950 shares, compared to its average volume of 5,316. The stock has a 50 day moving average price of $36.95 and a 200 day moving average price of $35.54. Tema Heart & Health ETF has a fifty-two week low of $31.95 and a fifty-two week high of $38.87. The firm has a market capitalization of $55.17 million, a PE ratio of 22.06 and a beta of 0.65.
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Read More
- Five stocks we like better than Tema Heart & Health ETF
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
